Preoperative Nutrition With Immune Enhancing Nutritional Supplement (Immunomodulation)

Stopped early · Not applicable

Conditions studied: Pancreatic Adenocarcinoma

In brief

The purpose of this study is to determine the optimal effective dose for preoperative nutritional supplementation with immunomodulators on immune function and perioperative outcomes following pancreaticoduodenectomy for pancreatic adenocarcinoma.

Key facts

Study ID

NCT02838966

Run by

University of Louisville

People needed

14

Starts

2014-08-01

Expected to finish

2019-11-11

Last updated by the study team

2021-07-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Over 18 years of age, of any race or sex, with histologic and/or radiologic proof of pancreatic adenocarcinoma (PDAC)
• PDAC that is deemed resectable by the operating surgeon
• Non-pregnant with an acceptable contraception method in premenopausal women
• Signed, written informed consent

You may not qualify if…

• Active bacterial, viral or fungal infection within 21 days of study entry
• Women who are pregnant or breast feeding
• Evidence of metastatic disease
• Presence of another malignancy with the exception of cervical carcinoma in situ and stage I basal or squamous cell carcinoma of the skin
• Inability to take oral or nasojejunal nutritional supplements
• Patients with immunodeficiency conditions
• Patients on chronic steroid therapy
• Patients with know sensitivity to arginine, omega-3 fatty acids or glutamine

Where it is running

• University of Louisville — Louisville, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.